Grey Fox Wealth Advisors’s Sanofi SNY Stock Holding History

Grey Fox Wealth Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-18	Closed	-$850	–	530
2025 Q3	$850	Buy	+18	New	+$869	﹤0.01%	585

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Grey Fox Wealth Advisors's SNY Position: Q4 2025 in Review

Grey Fox Wealth Advisors sold out of Sanofi (SNY) in Q4 2025, closing a stake of 18 shares — an estimated $850 sold.

Grey Fox Wealth Advisors first reported a position in SNY in Q3 2025 and held it in 1 quarter. The position peaked at $850 in Q3 2025. 755 funds tracked by Wall St. Rank hold SNY as of Q4 2025.

Grey Fox Wealth Advisors reported no remaining Sanofi position as of Q4 2025 after selling out during the quarter.
Grey Fox Wealth Advisors sold 18 Sanofi shares in Q4 2025, an estimated $850.
Grey Fox Wealth Advisors first reported a position in Sanofi in Q3 2025 and held it in 1 quarter.
Grey Fox Wealth Advisors's Sanofi position peaked at $850 in Q3 2025.
755 funds tracked by Wall St. Rank held Sanofi as of Q4 2025.

Based on Grey Fox Wealth Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.